Burden of gastrointestinal disease in the United States: 2012 update

…, JK Allen, SF Cook, RS Sandler, MD Kappelman… - Gastroenterology, 2012 - Elsevier
BACKGROUND & AIMS: Gastrointestinal (GI) diseases account for substantial morbidity,
mortality, and cost. Statistical analyses of the most recent data are necessary to guide GI …

The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States

MD Kappelman, SL Rifas–Shiman, K Kleinman… - Clinical …, 2007 - Elsevier
Background & Aims: Previous US studies of inflammatory bowel disease (IBD) prevalence
have sampled small, geographically restricted populations and may not be generalizable to …

Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international …

…, X Zhang, JF Colombel, MD Kappelman - Gastroenterology, 2020 - Elsevier
Background and Aims The impact of Coronavirus disease 2019 (COVID-19) on patients with
inflammatory bowel disease (IBD) is unknown. We sought to characterize the clinical course …

Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults

MD Kappelman, SL Rifas–Shiman, CQ Porter… - Gastroenterology, 2008 - Elsevier
BACKGROUND & AIMS: Data regarding the health care costs of inflammatory bowel disease
(IBD) in the United States are limited. The objectives of this study were to estimate the …

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study

…, MD Kappelman, S Steiner, DE Moulton, D Keljo… - The Lancet, 2017 - thelancet.com
Background Stricturing and penetrating complications account for substantial morbidity and
health-care costs in paediatric and adult onset Crohn's disease. Validated models to predict …

Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease

…, CA Pipkin, HH Herfarth, RS Sandler, MD Kappelman - Gastroenterology, 2012 - Elsevier
BACKGROUND & AIMS: Patients with inflammatory bowel disease (IBD) are at risk for
certain malignancies. We aimed to determine the risk of melanoma and nonmelanoma skin …

[HTML][HTML] Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population

MD Kappelman, KR Moore, JK Allen… - Digestive diseases and …, 2013 - Springer
Purpose Most US inflammatory bowel disease (IBD) epidemiology studies conducted to date
have sampled small, geographically restricted populations and have not examined time …

Effect of IBD medications on COVID-19 outcomes: results from an international registry

…, X Zhang, JF Colombel, MD Kappelman - Gut, 2021 - gut.bmj.com
Objective We sought to evaluate COVID-19 clinical course in patients with IBD treated with
different medication classes and combinations. Design Surveillance Epidemiology of …

Prevalence of eosinophilic esophagitis in the United States

…, CF Martin, NJ Shaheen, MD Kappelman - Clinical …, 2014 - Elsevier
Background & Aims Eosinophilic esophagitis (EoE) has become a major cause of upper
gastrointestinal morbidity in children and adults. However, there are few data on the nationwide …

Management of patients with Crohn's disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an international meeting

…, CM Griffiths, PD Higgins, MD Kappelman… - …, 2020 - gastrojournal.org
The 2020 annual meeting for IOIBD was scheduled to occur in March, but was cancelled
owing to the emergence of COVID-19. Given how this disease might affect patients with IBD …